Stock Price Quote

KOVAI MEDICAL CENTER & HOSPITAL LTD.

NSE : KOVAIBSE : 523323ISIN CODE : INE177F01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE4193.4045.4 (+1.09 %)
PREV CLOSE ( ) 4148.00
OPEN PRICE ( ) 4150.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3458
TODAY'S LOW / HIGH ( )4057.00 4271.95
52 WK LOW / HIGH ( )1913.6 4271.95
NSE2576.650 (0 %)
PREV CLOSE( ) 2576.65
OPEN PRICE ( ) 2512.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5822
TODAY'S LOW / HIGH( ) 2505.60 2637.70
52 WK LOW / HIGH ( )1903.35 2850
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 29-08 1985
Management Info
- Chairman Nalla G Palaniswami - Managing Director
Registered Office

Address Door No 99,Avanashi Road, ,
Coimbatore,
Tamil Nadu-641014

Phone 0422-4323800 / 4000 / 6803000

Email secretarialdept@kmchhospitals.com / accounts@kmchhospitals.com

Website www.kmchhospitals.com

Registrars Details
GNSA Investor Services (P) Ltd
Nelson Chambers,STA Department, 4th Floor,115 Nelson Manickam Road, Aminthakarai,Chennai
Listing : BSE, NSE

NEWS

16Apr Kovai Medical Center & Hospital inform
Kovai Medical Center & Hospital has informed that based on the reque..
03Apr Kovai Medical Center & Hospital inform
As per the requirement of Regulation 31 (4) and 31 (5) of the Securities..
26Mar Kovai Medical Center and Hospital info
Pursuant to Clause 4 of Schedule B of SEBI (Prohibition of Insider Tradi..
20Mar Kovai Medical Center & Hospital inform
Pursuant to regulation 30(2) of the Securities and Exchange Board of Ind..
19Mar Kovai Medical Center and Hospital info
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015, Kovai Medi..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit530.981157.67
Gross Profit 705.15 1552.21
Operating Profit 1012.042845.02
Net Sales 3211.0710197.47

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE)
peergroup  3564.55 (2.56%)
M.Cap ( in Cr)1675.34
Dr. Lal Pathlabs (BSE)
peergroup  2387.05 (2.45%)
M.Cap ( in Cr)19926.58
RainbowChildrenS Med (BSE)
peergroup  1343.85 (2.13%)
M.Cap ( in Cr)13640.30
Metropolis Health. (BSE)
peergroup  1805.55 (0.76%)
M.Cap ( in Cr)9249.62
Narayana Hrudayalay (BSE)
peergroup  1275.85 (1.02%)
M.Cap ( in Cr)26073.37

Shareholding Pattern

PROMOTERS 56.46%
NON-INSTITUTION 39.02%
MUTUAL FUNDS/UTI 3.8%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Kovai Medical Center & Hospital Ltd.

Kovai Medical Center & Hospital Ltd. was incorporated in the year 1985. Its today's share price is 4193.4. Its current market capitalisation stands at Rs 4588.53 Cr. In the latest quarter, company has reported Gross Sales of Rs. 10197.47 Cr and Total Income of Rs.10357.35 Cr. The company's management includes M Rathinasamy, R Ponmanikandan, K Kolandaswamy, AP Ammasaikutti, R Bhuvaneshwari, K Saminathan, AM Palanisamy, M Manickam, Kasi K Goundan, Purani P Palaniswami, M C Thirumoorthi, Mohan S Gounder, Arun N Palaniswami, Thavamani Devi Palaniswami, Nalla G Palaniswami.

It is listed on the BSE with a BSE Code of 523323 , NSE with an NSE Symbol of KOVAI and ISIN of INE177F01017. It's Registered office is at Door No 99,Avanashi Road, Coimbatore-641014, Tamil Nadu. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Haribhakti & Co, Haribhakti & Co LLP, VKS Aiyer & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.